Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
49 participants
INTERVENTIONAL
2021-10-15
2022-12-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* G1: Attentional training to avoid threatening, negative or pain-related information.
* G2: Attention training for vigilance for positive emotional information.
* G3: neutral attentional training (control group).
The study will be conducted from the patient's home via a connection to the protected site of the Nantes University Hospital. The various questionnaires will be completed from the secure site of the Nantes University Hospital and the computerized experimental tasks will be carried out using the Inquisit software (WEB version at home).
The study will begin with an evaluation of the patients' attention and psychological processes (completion of questionnaires + 2 attention tasks), during a follow-up visit to the urology department of the University Hospital of Nantes.
Then, an 8-week attentional re-training program (2 training sessions per week) will be proposed.
At the end of the 8 weeks, an evaluation (Questionnaires + attention tasks) will be offered to patients always from home.
Finally, a final evaluation, 4 weeks after the end of the re-training, will always be proposed from the patient's home.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
G1
Group 1
Attentional training to avoid threatening, negative or pain-related information.
G2
Group 2
Attention training for vigilance for positive emotional information.
G3
Group 3 (control group)
Neutral attentional training (control group).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Group 1
Attentional training to avoid threatening, negative or pain-related information.
Group 2
Attention training for vigilance for positive emotional information.
Group 3 (control group)
Neutral attentional training (control group).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient follow-up in the urology department of the University Hospital of Nantes
* Age between 18 and 65
* Good understanding of French, able to read and write.
* Serve correctly and painlessly with both hands
* Affiliated with a social security system
* Signed consent
* With internet access.
Exclusion Criteria
* Does not use both hands properly and painlessly
* Depression (BDI-II ≤18)
* Patient under guardianship, curatorship or judicial protection
* Pregnant or breastfeeding woman
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondation Apicil
OTHER
Nantes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Virginie Quistrebert-Davanne, PhD
Role: PRINCIPAL_INVESTIGATOR
Nantes University Hospital Nantes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Nantes
Nantes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC18_0361
Identifier Type: -
Identifier Source: org_study_id